Mitsubishi UFJ Asset Management
VKTX icon

Mitsubishi UFJ Asset Management’s Viking Therapeutics VKTX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
32,564
+18,590
+133% +$600K ﹤0.01% 827
2026
Q1 		$455K Hold
13,974
– – ﹤0.01% 879
2025
Q4 		$495K Hold
13,974
– – ﹤0.01% 883
2025
Q3 		$367K Hold
13,974
– – ﹤0.01% 911
2025
Q2 		$370K Buy
13,974
+3,974
+40% +$105K ﹤0.01% 889
2025
Q1 		$242K Hold
10,000
– – ﹤0.01% 939
2024
Q4 		$429K Buy
+10,000
New +$570K ﹤0.01% 890

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mitsubishi UFJ Asset Management's VKTX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Viking Therapeutics (VKTX) stake by 133% in Q2 2026, buying an estimated $600K and bringing the position to 32,564 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Mitsubishi UFJ Asset Management first reported a position in VKTX in Q4 2024 and has held it in 7 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 32,564 shares of Viking Therapeutics worth $1.27M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 18,590 Viking Therapeutics shares in Q2 2026, an estimated $600K.
  • Viking Therapeutics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #827 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Viking Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.